Duke Vaccine Institute Plays Integral Role in National Effort to Improve Flu Shots DHVI’s contracts potentially totaling $400 million are the largest in a federal drive to modernize flu vaccines As part of a massive national effort to improve and modernize flu shots, the...
New Research on Potent HIV Antibody Could Improve Vaccine Design Early mutation in neutralizing antibody gives it flexibility to adapt to virus’ changes
A Shortcut to Recreate Key HIV Antibody for Vaccines With new insights about the antibody’s pathway, researchers can bypass a previous hurdle
Researchers Find How Natural Killer Cells Regulate Protective HIV Antibodies The finding advances efforts to develop a vaccine that elicits protective HIV antibodies
Duke-Led Team Develops More Accurate Tool to Track New HIV Infections Population-based model would benefit research and public health initiatives worldwide
Duke Institute Tapped to Build a Rapid-Response System for Viral Pandemics Existing components at the Duke Human Vaccine Institute form the effort’s infrastructure
Investigational Vaccine Protected Monkeys from HIV-Like Virus The vaccine adds three more targets to a human vaccine candidate that showed promise
Researchers Map Pathways to Protective Antibodies for an HIV Vaccine The findings advance progress toward HIV vaccine design
